1. Home
  2. NAMS vs FHB Comparison

NAMS vs FHB Comparison

Compare NAMS & FHB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NAMS
  • FHB
  • Stock Information
  • Founded
  • NAMS 2019
  • FHB 1858
  • Country
  • NAMS Netherlands
  • FHB United States
  • Employees
  • NAMS N/A
  • FHB N/A
  • Industry
  • NAMS Biotechnology: Pharmaceutical Preparations
  • FHB Major Banks
  • Sector
  • NAMS Health Care
  • FHB Finance
  • Exchange
  • NAMS Nasdaq
  • FHB Nasdaq
  • Market Cap
  • NAMS 3.1B
  • FHB 3.0B
  • IPO Year
  • NAMS N/A
  • FHB 2016
  • Fundamental
  • Price
  • NAMS $36.14
  • FHB $24.90
  • Analyst Decision
  • NAMS Strong Buy
  • FHB Sell
  • Analyst Count
  • NAMS 10
  • FHB 9
  • Target Price
  • NAMS $43.70
  • FHB $27.67
  • AVG Volume (30 Days)
  • NAMS 1.4M
  • FHB 1.1M
  • Earning Date
  • NAMS 11-06-2025
  • FHB 10-24-2025
  • Dividend Yield
  • NAMS N/A
  • FHB 4.16%
  • EPS Growth
  • NAMS N/A
  • FHB 16.35
  • EPS
  • NAMS N/A
  • FHB 2.05
  • Revenue
  • NAMS $64,006,000.00
  • FHB $824,314,000.00
  • Revenue This Year
  • NAMS N/A
  • FHB $10.40
  • Revenue Next Year
  • NAMS $1.67
  • FHB $2.18
  • P/E Ratio
  • NAMS N/A
  • FHB $12.21
  • Revenue Growth
  • NAMS 762.15
  • FHB 1.80
  • 52 Week Low
  • NAMS $14.06
  • FHB $20.32
  • 52 Week High
  • NAMS $41.47
  • FHB $28.80
  • Technical
  • Relative Strength Index (RSI)
  • NAMS 60.09
  • FHB 55.16
  • Support Level
  • NAMS $34.34
  • FHB $23.35
  • Resistance Level
  • NAMS $37.21
  • FHB $25.26
  • Average True Range (ATR)
  • NAMS 2.47
  • FHB 0.62
  • MACD
  • NAMS -0.34
  • FHB 0.16
  • Stochastic Oscillator
  • NAMS 46.32
  • FHB 86.23

About NAMS NewAmsterdam Pharma Company N.V.

NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments.

About FHB First Hawaiian Inc.

First Hawaiian Inc is a bank holding company. It provides a diversified range of banking services to consumer and commercial customers, including deposit products, lending services, and wealth management and trust services. The company offers a variety of deposit products to its customers, including checking and savings accounts and other types of deposit accounts. It provides commercial and industrial lending, including auto dealer flooring, commercial real estate, and construction lending. It also offers comprehensive consumer lending services focused on residential real estate lending, indirect auto financing, and other consumer loans. The company's segments are Retail Banking, Commercial Banking, and Treasury, and others of which key revenue is derived from Retail Banking.

Share on Social Networks: